The latest price target for Bruker (NASDAQ:BRKR) was reported by Wells Fargo on August 27, 2024. The analyst firm set a price target for $78.00 expecting BRKR to rise to within 12 months (a possible 14.27% upside). 15 analyst firms have reported ratings in the last year.

The latest analyst rating for Bruker (NASDAQ:BRKR) was provided by Wells Fargo, and Bruker initiated their overweight rating.

The last upgrade for Bruker Corp happened on February 14, 2024 when JP Morgan raised their price target to $90. JP Morgan previously had a neutral for Bruker Corp.

There is no last downgrade for Bruker.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Bruker, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Bruker was filed on August 27, 2024 so you should expect the next rating to be made available sometime around August 27, 2025.

While ratings are subjective and will change, the latest Bruker (BRKR) rating was a initiated with a price target of $0.00 to $78.00. The current price Bruker (BRKR) is trading at is $68.26, which is within the analyst’s predicted range.